Tag | Content |
---|
EnhancerAtlas ID | HS023-25684 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr9:129810260-129812280 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
HLTF | MA0109.1 | chr9:129811011-129811021 | ATATAAGGTT | - | 6.02 | IRF1 | MA0050.2 | chr9:129811225-129811246 | TCTTGGTTTCTCTTTCTTTGC | + | 6.24 | TBXT | MA0009.2 | chr9:129810964-129810980 | TCACACTTGAGTGTGA | - | 6.26 | TBXT | MA0009.2 | chr9:129810964-129810980 | TCACACTTGAGTGTGA | + | 6.36 | ZNF410 | MA0752.1 | chr9:129811781-129811798 | TTACATTATGGGATGGG | - | 6 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_42713 | chr9:129810233-129811166 | Lung | SE_42713 | chr9:129811526-129813652 | Lung |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr9 | 129811267 | 129811766 | chr9 | 129810942 | 129811263 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH09I127048 | chr9 | 129810281 | 129812810 |
|
Enhancer Sequence | GCACTGGCTC AGACCTCCTC ATCTCTCACT GAGACCATTG CATCAGTTTT CTAATGGGTG 60 TCTCTATCCT TGCAAAGGAT CTCATCTATC ACCCTGCTCA GAAGCCTCTG AAAGTCCCTG 120 TGTAGCATAG TGTTTTAGCT CCTTCCTCTC ACCTTGTTGC ACCAGTCCTC CCCTCCTCAC 180 CACACACCCA ATCTGGTCTT TTTCTCCCTC CCCACCCTCA TCGTCACTCA CAACCCCCAC 240 CCACAGCACT CCTGCAACAC CAGTGCTTTC AGCCTATCCA GCCGTCCCTG GTCATGGAAC 300 ATATGGCCAC ACTTCAGTCT TCTCTTGTTT AAAGTCTACC CATCTTTCAA GGCCTATCTT 360 CTTCGAGAAG CCTTCCTCTG TCATTACCTC TCTCATACTT TGGTTTACTG TTTGAACTTC 420 TTCCATGGCC ACTATTACCA GCTGCCTTCT AATACAGCGA TTCCTTAAGG ATTCTGCCTC 480 CTCCTTTGGT CACCTCAATT TCAGGAAGGT CTGGGCTCCC AGTGCCTGGA GCCCACACAC 540 CGAAGGGGCT TCATGGAACT CTGCTGAATC GAGTTGTTGA CTCAGAGTTG CCTCTGCACA 600 ACATGGACTG CAGTTCCAGA GTCAATGCTT CCATGTTCCG TAATATGCCA TAAACGTGTG 660 ATTCTTTGAC ATGCAGGAAT CTACTAAATT GTACATGTAA ACTATCACAC TTGAGTGTGA 720 TAATATGCCA TAAAAATGTA CACATATTAA AATATAAGGT TTATGGGCAT CCCATTTGGT 780 ATTTAGAAAA ACTTTTTTCT GTAACTGGCT AGTAAATATT TGAGTCTGAG CTTAATTGTG 840 GGCAATTCCT TGGAAAAAAA TGATTCTATG GAAACCCAGT CATGTCCTGG AGGCAACCAC 900 AGATAATTAC ACTGAGAAAA CATTTCTATA ATACTCCTGC TTAATATAAA AAGCACATTG 960 TTGATTCTTG GTTTCTCTTT CTTTGCTTTC TATTTGAAAA GTGATGGTAT TTCAATAACG 1020 AGAATACATT TTATTGCAGC AGTAAGCTTG TTTTATTAGC TCTGGAATAT CCTTAACTAT 1080 ATTTTTCCCT ATAAAGTTTA GGGGTTTTAG ATGCCTTGCC TTCTTTTTAA TTCTCCCTAT 1140 GCCCCGTGCT TTGCCTGGCT CTCCACCTTT CTTTGCAGTG CTGTCATTGC ACTCTTGGGC 1200 ATCCGTGTTT CACATAGAAC TGTTGTTACA GAAGTGAAAC ATAAACAGGA AGAGCTAGCC 1260 ACTTCCCAGC ATTTCTTGGC ATGAGTCTCT TCCGTTGCAT TGAGGTGCCA TGTGAGTCAG 1320 CTCCACTCTG GTAGATGACT TTCCTGTTCC ACCATCAGAC ACAGGGGTTC AGGCTGTTGC 1380 AGTATGTGAG AGGTCAAGCA TGAATGGGCT TCTGAACCAA AGCTACCATC ATACCCTTTT 1440 TGGTGCATGC TGTCTCCGGG AAAACATGCC CTGTAACATG CATTGCTTTA TGGAACTTTG 1500 AAAGAGATAC TTCCATATCA TTTACATTAT GGGATGGGCC TCTCCCAAAA AATTAAATTT 1560 GTTAAAATTG TGCAAATATT GATGAATCCT CCTTATCTTA GGGCTGGCTG GGGATATGGA 1620 CCTCACAAGT GTTCCTACCA ATATACATGT CCCTTTGGCT CTTTGTCCAT CTGTCCCTCC 1680 ATCCACCCAT CATCTATGAT CTCCCCACAA CTGGGATCCT TCTGAGCAGG AATTCAGTCT 1740 GATTCATCTC AGGATTCCCA GCAACTCTTC TCGAGACTCG TGTCACGGAG GCCCAGCGCT 1800 CCCTGGGATG ACGAGGAAAG TGCTGCTTTC TCTTGGCACT GCAGTGTGCA CTGGAGACAG 1860 GGTGCTGAGA ACACGGCCCA TTTGCAGGGT TGGGTGCTGT AGAGGAACTC TTTAACTCAT 1920 GTGACCCCAG GCTATCCTCT CCCAGTTTCC TGACCTCTTG GAAATCCCAT AACAGCGGTG 1980 GGCAAGGGGG ACACGGGTGG TCCAGCAATT AACAACTTTT 2020
|